Researcher
Evelyne Lerut
- Disciplines:Macromolecular and materials chemistry, Laboratory medicine, Morphological sciences
Affiliations
- Translational Cell & Tissue Research (Division)
Member
From1 Aug 2002 → 30 Sep 2019
Projects
1 - 10 of 11
- Optimization and validation of mRNA biomarkers for antibody-mediated rejection after kidney transplantationFrom1 Oct 2017 → 30 Sep 2019Funding: IOF - Industrial Research Fund
- Targeting mitotic-exit phosphatases for cancer therapy.From1 Oct 2014 → 30 Sep 2019Funding: BOF - Concerted Research Project from 1994
- The effect of changes in the innate and adaptive immune compartment within the renal allograft on graft outcomeFrom1 Oct 2013 → 30 Sep 2018Funding: FWO fellowships
- Study of the genetic variations in the TMPRSS2 control regions and their effects on prostate cancer development .From1 Jan 2013 → 31 Dec 2016Funding: FWO research project
- Hedgehog signaling in prostate cancer: clinical relevance and its potential as a target for radiosensitizationFrom1 Sep 2012 → 13 Jan 2017Funding: Own budget, for example: patrimony, inscription fees, gifts
- MicroRNA-profiling of renal cell carcinoma: in pursuit of tailoring individualized adjuvant thrapy.From1 Jan 2011 → 31 Dec 2014Funding: Private funding of national origin - undefined
- Implementation of functional imaging and molecular diagnostics for patient-tailored treatment of prostate cancer.From15 Sep 2009 → 30 Jun 2015Funding: Ministery of Social Affairs, Public Health and Environment
- Prognostic and therapeutic value of gene expression profiles in renal cancerFrom1 Aug 2009 → 31 May 2018Funding: Own budget, for example: patrimony, inscription fees, gifts
- Implementation of functional imaging and molecular diagnostics for patient-tailored treatment of prostate cancer.From1 Jan 2009 → 30 Sep 2015Funding: Ministery of Social Affairs, Public Health and Environment
- The prognostic value of gene expression profiling in renal cell carcinoma.From1 Jan 2009 → 31 Dec 2012Funding: FWO research project
Publications
1 - 10 of 168
- Replicative senescence and arteriosclerosis after kidney transplantation(2020)
Authors: Katrien De Vusser, Evelyne Lerut, Dirk Kuypers, Tim Nawrot, Maarten Naesens
Pages: 1984 - 1995 - Bone metastases and age are associated with earlier dose reductions in metastatic clear-cell renal cell carcinoma patients treated with angiogenesis inhibitors(2019)
Authors: Hans Wildiers, Annelies Verbiest, Herlinde Dumez, Evelyne Lerut, Steven Pans, Maarten Albersen, Benoit Beuselinck
Pages: 414 - 423 - ABCG2 Polymorphism rs2231142 and hypothyroidism in metastatic renal cell carcinoma patients treated with sunitinib(2019)
Authors: Diether Lambrechts, Annelies Verbiest, Evelyne Lerut, Brigitte Decallonne, Patrick Schöffski, Oliver Bechter, Benoit Beuselinck
Pages: 180 - 188 - Prospective evaluation of hypogonadism in male metastatic renal cell carcinoma patients treated with targeted therapies(2019)
Authors: Annelies Verbiest, Kevin Punie, Oliver Bechter, Hans Wildiers, Evelyne Lerut, Herlinde Dumez, Brigitte Decallonne, Paul Clement, Dirk Vanderschueren, Maarten Albersen, et al.
Pages: 169 - 179 - Fibroblast Growth Factor Receptor-2 Polymorphism rs2981582 is Correlated With Progression-free Survival and Overall Survival in Patients With Metastatic Clear-cell Renal Cell Carcinoma Treated With Sunitinib(2019)
Authors: Maxime Vanmechelen, Diether Lambrechts, Annelies Verbiest, Patrick Schöffski, Herlinde Dumez, Evelyne Lerut, Maarten Albersen, Benoit Beuselinck
Pages: E235 - E246 - Histological picture of ABMR without HLA-DSA: Temporal dynamics of effector mechanisms are relevant in disease reclassification(2019)
Authors: Aleksandar Senev, Jasper Callemeyn, Evelyne Lerut, Marie-Paule Emonds, Maarten Naesens
Pages: 954 - 955 - Histological picture of antibody-mediated rejection without donor-specific anti-HLA antibodies: Clinical presentation and implications for outcome(2019)
Authors: Aleksandar Senev, Maarten Coemans, Evelyne Lerut, Dirk Kuypers, Ben Sprangers, Marie-Paule Emonds, Maarten Naesens
Pages: 763 - 780 - Natural killer cell infiltration is discriminative for antibody-mediated rejection and predicts outcome after kidney transplantation(2019)
Authors: Saleh Yazdani, Jasper Callemeyn, Evelyne Lerut, Line Heylen, Lieven Thorrez, Dirk Kuypers, Ben Sprangers, Frans Schuit, Maarten Naesens
Pages: 188 - 198 - Not Every Case of Temporal Arteritis Is Giant Cell Arteritis. Microscopic Polyangiitis Involving the Temporal Artery(2018)
Authors: Liesbet Henckaerts, Evelyne Lerut, Erik Verbeken, Daniel Engelbert Blockmans
Pages: 440 - 442 - Molecular Subtypes of Clear-cell Renal Cell Carcinoma are Prognostic for Outcome After Complete Metastasectomy(2018)
Authors: Annelies Verbiest, Evelyne Lerut, Raymond Oyen, Lorenzo Tosco, Steven Joniau, Hendrik Van Poppel, Dirk Van Raemdonck, Agnieszka Wozniak, Benoit Beuselinck
Pages: 474 - 480